vs
太平洋生物科学（ASMB）与JOINT Corp（JYNT）财务数据对比。点击上方公司名可切换其他公司
JOINT Corp的季度营收约是太平洋生物科学的1.4倍（$15.2M vs $10.8M），JOINT Corp净利率更高（6.5% vs -85.2%，领先91.8%），太平洋生物科学同比增速更快（57.6% vs 3.1%），JOINT Corp自由现金流更多（$334.7K vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
JOINT Corp是美国领先的脊椎按摩护理诊所运营方与特许经营商，主打高性价比的脊椎护理服务，推出会员制护理方案，面向寻求非侵入式肌肉骨骼疼痛管理及日常健康调理的消费者。
ASMB vs JYNT — 直观对比
营收规模更大
JYNT
是对方的1.4倍
$10.8M
营收增速更快
ASMB
高出54.5%
3.1%
净利率更高
JYNT
高出91.8%
-85.2%
自由现金流更多
JYNT
多$15.5M
$-15.2M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $15.2M |
| 净利润 | $-9.2M | $991.1K |
| 毛利率 | — | 81.4% |
| 营业利润率 | -100.9% | 4.9% |
| 净利率 | -85.2% | 6.5% |
| 营收同比 | 57.6% | 3.1% |
| 净利润同比 | 4.3% | 5510.5% |
| 每股收益（稀释后） | $-0.72 | $0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBJYNT
| Q4 25 | — | $15.2M | ||
| Q3 25 | $10.8M | $13.4M | ||
| Q2 25 | $9.6M | $13.3M | ||
| Q1 25 | $9.4M | $13.1M | ||
| Q4 24 | $7.4M | $14.7M | ||
| Q3 24 | $6.8M | $30.2M | ||
| Q2 24 | $8.5M | $30.3M | ||
| Q1 24 | $5.8M | $29.7M |
净利润ASMBJYNT
| Q4 25 | — | $991.1K | ||
| Q3 25 | $-9.2M | $855.0K | ||
| Q2 25 | $-10.2M | $93.4K | ||
| Q1 25 | $-8.8M | $967.8K | ||
| Q4 24 | — | $17.7K | ||
| Q3 24 | $-9.6M | $-3.2M | ||
| Q2 24 | $-11.2M | $-3.6M | ||
| Q1 24 | $-9.1M | $947.0K |
毛利率ASMBJYNT
| Q4 25 | — | 81.4% | ||
| Q3 25 | — | 80.1% | ||
| Q2 25 | — | 79.1% | ||
| Q1 25 | — | 77.3% | ||
| Q4 24 | — | 78.4% | ||
| Q3 24 | — | 90.7% | ||
| Q2 24 | — | 90.7% | ||
| Q1 24 | — | 90.9% |
营业利润率ASMBJYNT
| Q4 25 | — | 4.9% | ||
| Q3 25 | -100.9% | 1.2% | ||
| Q2 25 | -115.2% | -8.6% | ||
| Q1 25 | -105.5% | -5.2% | ||
| Q4 24 | — | 5.5% | ||
| Q3 24 | -160.1% | -1.6% | ||
| Q2 24 | -143.0% | -5.9% | ||
| Q1 24 | -185.5% | -1.4% |
净利率ASMBJYNT
| Q4 25 | — | 6.5% | ||
| Q3 25 | -85.2% | 6.4% | ||
| Q2 25 | -105.9% | 0.7% | ||
| Q1 25 | -93.6% | 7.4% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | -140.4% | -10.5% | ||
| Q2 24 | -130.7% | -11.9% | ||
| Q1 24 | -156.9% | 3.2% |
每股收益（稀释后）ASMBJYNT
| Q4 25 | — | $0.06 | ||
| Q3 25 | $-0.72 | $0.06 | ||
| Q2 25 | $-1.33 | $0.01 | ||
| Q1 25 | $-1.17 | $0.06 | ||
| Q4 24 | — | $0.01 | ||
| Q3 24 | $-1.51 | $-0.21 | ||
| Q2 24 | $-1.98 | $-0.24 | ||
| Q1 24 | $-1.66 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $23.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $15.1M |
| 总资产 | $240.0M | $61.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBJYNT
| Q4 25 | — | $23.6M | ||
| Q3 25 | $22.5M | $29.7M | ||
| Q2 25 | $24.0M | $29.8M | ||
| Q1 25 | $23.4M | $21.9M | ||
| Q4 24 | $38.3M | $25.1M | ||
| Q3 24 | $28.5M | $20.7M | ||
| Q2 24 | $19.2M | $17.5M | ||
| Q1 24 | $18.7M | $18.7M |
股东权益ASMBJYNT
| Q4 25 | — | $15.1M | ||
| Q3 25 | $182.7M | $22.7M | ||
| Q2 25 | $18.1M | $23.2M | ||
| Q1 25 | $27.1M | $22.8M | ||
| Q4 24 | $33.4M | $20.7M | ||
| Q3 24 | $26.0M | $20.5M | ||
| Q2 24 | $34.7M | $23.2M | ||
| Q1 24 | $32.6M | $26.2M |
总资产ASMBJYNT
| Q4 25 | — | $61.0M | ||
| Q3 25 | $240.0M | $69.4M | ||
| Q2 25 | $80.8M | $73.2M | ||
| Q1 25 | $99.0M | $80.1M | ||
| Q4 24 | $119.2M | $83.2M | ||
| Q3 24 | $100.3M | $79.6M | ||
| Q2 24 | $115.3M | $82.4M | ||
| Q1 24 | $119.9M | $85.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $1.8M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $334.7K |
| 自由现金流率自由现金流/营收 | -140.7% | 2.2% |
| 资本支出强度资本支出/营收 | 0.4% | 9.9% |
| 现金转化率经营现金流/净利润 | — | 1.86× |
| 过去12个月自由现金流最近4个季度 | — | $-1.9M |
8季度趋势，按日历期对齐
经营现金流ASMBJYNT
| Q4 25 | — | $1.8M | ||
| Q3 25 | $-15.1M | $1.8M | ||
| Q2 25 | $-16.8M | $868.6K | ||
| Q1 25 | $-23.4M | $-3.7M | ||
| Q4 24 | $-51.1M | $9.4M | ||
| Q3 24 | $-15.2M | $3.4M | ||
| Q2 24 | $-17.1M | $-973.5K | ||
| Q1 24 | $-18.4M | $2.8M |
自由现金流ASMBJYNT
| Q4 25 | — | $334.7K | ||
| Q3 25 | $-15.2M | $1.5M | ||
| Q2 25 | — | $363.6K | ||
| Q1 25 | — | $-4.0M | ||
| Q4 24 | $-51.1M | $8.2M | ||
| Q3 24 | — | $3.2M | ||
| Q2 24 | $-17.1M | $-1.2M | ||
| Q1 24 | $-18.4M | $2.4M |
自由现金流率ASMBJYNT
| Q4 25 | — | 2.2% | ||
| Q3 25 | -140.7% | 10.9% | ||
| Q2 25 | — | 2.7% | ||
| Q1 25 | — | -30.8% | ||
| Q4 24 | -695.2% | 55.9% | ||
| Q3 24 | — | 10.6% | ||
| Q2 24 | -200.6% | -4.1% | ||
| Q1 24 | -317.7% | 8.1% |
资本支出强度ASMBJYNT
| Q4 25 | — | 9.9% | ||
| Q3 25 | 0.4% | 2.4% | ||
| Q2 25 | 0.0% | 3.8% | ||
| Q1 25 | 0.0% | 2.5% | ||
| Q4 24 | 0.4% | 8.1% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | 0.2% | 0.9% | ||
| Q1 24 | 0.2% | 1.3% |
现金转化率ASMBJYNT
| Q4 25 | — | 1.86× | ||
| Q3 25 | — | 2.07× | ||
| Q2 25 | — | 9.30× | ||
| Q1 25 | — | -3.82× | ||
| Q4 24 | — | 532.98× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.97× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASMB
暂无分部数据
JYNT
| Transferred At Point In Time | $12.8M | 84% |
| Transferred Over Time | $2.4M | 16% |
